Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention
Keaven M Anderson, Robert M Califf, Gregg W Stone, Franz-Josef Neumann, Gilles Montalescot, Dave P Miller, James J Ferguson III, James T Willerson, Harlan F Weisman, Eric J TopolVolume:
37
Year:
2001
Language:
english
DOI:
10.1016/s0735-1097(01)01290-6
File:
PDF, 213 KB
english, 2001